Please Wait.....
Report
Global Stem Cell Therapy Market Report and Forecast 2023-2031
Market Report I 2023-05-15 I 147 Pages I EMR Inc.
Global Stem Cell Therapy Market Report and Forecast 2023-2031
Global Stem Cell Therapy Market Outlook
The global stem cell therapy market value was USD 246 million in 2022, driven by the increasing demand for regenerative therapies structure across the globe. The market size is anticipated to grow at a CAGR of 18.5% during the forecast period of 2023-2031 to achieve a value of USD 1133.4 million by 2031.
Stem Cell Therapy Introduction
Stem cells are unique, undifferentiated cells with the ability to differentiate into specialized cell types and self-renew to produce more stem cells. This extraordinary feature of stem cells has made them a subject of immense interest in regenerative medicine, as they hold the potential to repair or replace damaged or diseased tissues and organs. Stem cell research has led to ground-breaking advancements in the treatment of various conditions, including spinal cord injuries, Alzheimer's disease, Parkinson's disease, and cancer, among others.
Stem Cell Therapy Market Scenario
The global stem cell market has experienced significant growth in recent years, driven by factors such as the rising prevalence of chronic diseases, an aging population, and the increasing demand for regenerative therapies. The market has also been fueled by ongoing advancements in stem cell research, the development of novel stem cell-based therapies, and a supportive regulatory environment. Furthermore, the growing awareness of the potential benefits of stem cell therapies and increasing investments in research and development have contributed to the market's expansion.
North America: The largest market for stem cells, driven by factors such as advanced healthcare infrastructure, a strong focus on research and development, and the high prevalence of chronic diseases.
Europe: The second-largest market, with increasing demand for stem cell therapies due to a growing awareness of their potential benefits and a supportive regulatory framework.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Stem Cell Therapy Market Segmentations
Market Breakup by Treatment
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- Syngeneic Stem Cell Therapy
Market Breakup by Product Type
- Adult Stem Cell
- Hematopoietic Stem Cells (Blood Stem Cells)
- Mesenchymal Stem Cells
- Neural Stem Cells
- Epithelial/Skin Stem Cells
- Other Adult Stem Cells
- Human Embryonic Cell
- Pluripotent Stem Cell
- Others
Market Breakup by Application
- Musculoskeletal Disorders
- Neurological Disorders
- Oncology Disorders
- Cardiovascular Disorders
- Cancers
- Wounds and Injuries
- Others
Market Breakup by Technology
- Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
- Cell Production
- Therapeutic Cloning
- In Vitro Fertilization
- Cell Culture
- Isolation
- Cryopreservation
- Expansion And Sub-Culture
Market Breakup by End User
- Pharmaceutical And Biotechnology Companies
- Hospitals & Cell Banks
- Academic & Research Institutes
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Stem Cell Therapy Market
Some key trends of the market are as follows:
- Increasing demand for regenerative therapies: The growing prevalence of chronic diseases and an aging population have resulted in a higher demand for regenerative therapies, driving the growth of the stem cell market.
- Advancements in stem cell research: Ongoing research and development efforts have led to the discovery of novel stem cell-based therapies and techniques, fueling market growth.
- Supportive regulatory environment: Regulatory bodies worldwide are increasingly recognizing the potential benefits of stem cell therapies, leading to a more favorable environment for the development and commercialization of these treatments.
Stem Cell Therapy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- Bayer AG
- Stem Cell Therapys International Group, Ltd.
- Takeda Pharmaceutical Company Limited
- MEDIPOST Co., Ltd.
- JCR Pharmaceuticals Co., Ltd.
- Astellas Pharma Inc.
- Mesoblast Ltd.
- Novadip Biosciences S.A.
- Nuvasive Inc
- Molecular Devices Corporation
- ?Amgen Inc
- GENEA BIOCELLS
- WAISMAN BIOMANUFACTURING
- TIGENIX
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stem Cell Therapy Market Overview
3.1 Global Stem Cell Therapy Market Historical Value (2016-2022)
3.2 Global Stem Cell Therapy Market Forecast Value (2023-2031)
4 Global Stem Cell Therapy Market Landscape
4.1 Global Stem Cell Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Therapy Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Treatment
4.2.3 Analysis by Applications
5 Global Stem Cell Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stem Cell Therapy Market Segmentation
6.1 Global Stem Cell Therapy Market by Treatment
6.1.1 Market Overview
6.1.2 Allogeneic Stem Cell Therapy
6.1.3 Autologous Stem Cell Therapy
6.1.4 Syngeneic Stem Cell Therapy
6.2 Global Stem Cell Therapy Market by Product Type
6.2.1 Market Overview
6.2.2 Adult Stem Cell
6.2.2.1 Hematopoietic Stem Cells (Blood Stem Cells)
6.2.2.2 Mesenchymal Stem Cells
6.2.2.3 Neural Stem Cells
6.2.2.4 Epithelial/Skin Stem Cells
6.2.2.5 Other Adult Stem Cells
6.2.3 Human Embryonic Cell
6.2.4 Pluripotent Stem Cell
6.2.5 Others
6.3 Global Stem Cell Therapy Market by Application
6.3.1 Market Overview
6.3.2 Musculoskeletal Disorders
6.3.3 Neurological Disorders
6.3.4 Oncology Disorders
6.3.5 Cardiovascular Disorders
6.3.6 Cancers
6.3.7 Wounds and Injuries
6.3.8 Others
6.4 Global Stem Cell Therapy Market by Technology
6.4.1 Market Overview
6.4.2 Cell Acquisition
6.4.2.1 Bone Marrow Harvest
6.4.2.2 Umbilical Blood Cord
6.4.2.3 Apheresis
6.4.3 Cell Production
6.4.3.1 Therapeutic Cloning
6.4.3.2 In Vitro Fertilization
6.4.3.3 Cell Culture
6.4.3.4 Isolation
6.4.4 Cryopreservation
6.4.5 Expansion And Sub-Culture
6.5 Global Stem Cell Therapy Market by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical And Biotechnology Companies
6.5.3 Hospitals & Cell Banks
6.5.4 Academic & Research Institutes
6.6 Global Stem Cell Therapy Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Stem Cell Therapy Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stem Cell Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stem Cell Therapy Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Stem Cell Therapy Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stem Cell Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 Thermo Fisher Scientific
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bayer AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Stem Cell Therapys International Group, Ltd.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Takeda Pharmaceutical Company Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 MEDIPOST Co., Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 JCR Pharmaceuticals Co., Ltd.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Astellas Pharma Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Mesoblast Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Novadip Biosciences S.A.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Nuvasive Inc
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Molecular Devices Corporation
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Amgen Inc
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 GENEA BIOCELLS
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 WAISMAN BIOMANUFACTURING
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 TIGENIX
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Global Stem Cell Therapy Market- Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security